Biopharma Deals, Layoffs, and Funding
Kilder
- Endpoints: PTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auction
- Raps: Recon: FDA grants Concerta generic withdrawal hearing; Ivonescimab wins first-line NSCLC nod in China - RAPS
- Bizjournals: Bankrupt Sangamo scores at least $163 million in asset sale, which had two big winners - The Business Journals
- Endpoints: Zealand's royalty deal; Khartis raises money for TED drug
- BioSpace: July's biopharma layoffs affect 466 employees, a 94% year-over-year drop
- Endpoints: Ovid and Takeda's epilepsy drug gets new life at Perceptive-backed NewCo
- wikimedia: Photo by Usposxv / Wikimedia Commons / CC0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.